|
Recombinant Human Thyroid Stimulating Hormone Clinical Trials
2 actively recruiting trials
Top Sponsors
- Nanjing First Hospital, Nanjing Medical University2
Indications
- Cancer2
- Recombinant Human Thyroid Stimulating Hormone1
- Radiotherapy; Complications1
- Thyroid Stimulating; Hormone, C1
- DTC - Differentiated Thyroid Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.